Enantioselective Addition of Cyanide to CF 3 ‐Substituted Alkylidenemalonates: Construction of Trifluoromethylated All‐Carbon Quaternary Stereocenters
- 3 May 2018
- journal article
- research article
- Published by Wiley in ChemistrySelect
- Vol. 3 (17) , 4838-4843
Abstract
The construction of a new class of chiral organofluorine compounds with an all‐carbon stereocenter bearing a CF 3 group was disclosed. The cinchona alkaloid based phase transfer catalyzed asymmetric conjugated cyanation of CF 3 substituted alkylidene malonates have been developed. The nitrile products were achieved in excellent yield with good enantioselectivity. The chirality of product increased up to 98% by recrystallization.Keywords
Funding Information
- CSIR-CSMCRI (168/2017)
- CSIR
- SERB (DST)
- AcSIR
This publication has 49 references indexed in Scilit:
- Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)Chemical Reviews, 2013
- Introduction of Fluorine and Fluorine‐Containing Functional GroupsAngewandte Chemie International Edition, 2013
- Modern Fluoroorganic Chemistry2013
- Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full AgonistACS Medicinal Chemistry Letters, 2012
- Asymmetric Construction of Stereogenic Carbon Centers Featuring a Trifluoromethyl Group from Prochiral Trifluoromethylated SubstratesChemical Reviews, 2010
- Design, Synthesis, and Biological Evaluation of (2R,αS)-3,4-Dihydro-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)-phenyl]-α-(trifluoromethyl)-1(2H)-quinolineethanol as Potent and Orally Active Cholesteryl Ester Transfer Protein InhibitorJournal of Medicinal Chemistry, 2009
- Fluorine in medicinal chemistryChemical Society Reviews, 2007
- Process Research and Development of an NK-1 Receptor Antagonist. Enantioselective Trifluoromethyl Addition to a Ketone in the Preparation of a Chiral IsochromanOrganic Process Research & Development, 2007
- Fluorine in Pharmaceuticals: Looking Beyond IntuitionScience, 2007
- Synthesis and SAR of [1,2,4]Triazolo[1,5-a]pyrimidines, a Class of Anticancer Agents with a Unique Mechanism of Tubulin InhibitionJournal of Medicinal Chemistry, 2006